metoprolol has been researched along with Central Serous Retinopathy in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate ocular safety of intravitreal metoprolol in eyes with central serous chorioretinopathy." | 8.12 | Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy. ( Chaves, L; de Azeredo Bastos, TM; Gonçalves, AN; Jorge, R; Messias, A, 2022) |
| "To investigate ocular safety of intravitreal metoprolol in eyes with central serous chorioretinopathy." | 4.12 | Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy. ( Chaves, L; de Azeredo Bastos, TM; Gonçalves, AN; Jorge, R; Messias, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonçalves, AN | 1 |
| Messias, A | 1 |
| Chaves, L | 1 |
| de Azeredo Bastos, TM | 1 |
| Jorge, R | 1 |
1 other study available for metoprolol and Central Serous Retinopathy
| Article | Year |
|---|---|
Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Electroretinography; Fluorescein Angiography; Humans; Intravitreal | 2022 |